Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials

PURPOSE: Intravesical BCG (bacille Calmette–Guérin) instillation in patients with non-muscle-invasive bladder cancer decreases the risk for tumor recurrence and progression. After one BCG product was discontinued, a chronic global BCG shortage occurred. We focused on identifying a reduced dose of BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Se Young, Ha, Moon Soo, Kim, Jung Hoon, Chi, Byung Hoon, Kim, Jin Wook, Chang, In Ho, Kim, Tae-Hyoung, Myung, Soon Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2022
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902423/
https://www.ncbi.nlm.nih.gov/pubmed/35244987
http://dx.doi.org/10.4111/icu.20210340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902423/
https://www.ncbi.nlm.nih.gov/pubmed/35244987
http://dx.doi.org/10.4111/icu.20210340

Ejemplares similares